Sarah Houlton, PhD, is Pharmaceutical Executive’s international correspondent.
With a weak pound being outpaced by the euro, many hospitals are sending drugs to the Continent for higher profits. What can NHS do to stop this practice?
Statins should be given to people with high blood pressure or diabetes, even if they don?t have heart disease, according to a study published in the British Medical Journal.
UK Health Institute leaves guidance unchanged in case against Eisai and Pfizer; more research on NICE methodology needed.
Diversity of ethnic groups and prevalence of Spanish language make Latin America an attractive destination for clinical trials.
It could be the end of the road for the UK's biotech firms if drastic action isn't taken soon.
EC proposal loosens restrictions on drug packaging and information dissemination.
The new EU directive looks to reduce, refine, and eventually replace animal testing
In Europe, it's different strokes for different folks at the top regulatory agencies
Tensions mount as stakeholders in the UK health industry attempt to work out drug cost problems
Supply Chain Strategy: Managing risk and opportunity in a changing global landscape
Sponsored By PricewaterhouseCoopers LLP Optimizing the Multi-Sponsor REMS Experience (Risk Evaluation & Mitigation Strategies)
Sponsored By PricewaterhouseCoopers LLP Effective Resource Planning: Reducing Clinical Project Risk and Operating Cost
Sponsored By ClearTrial